We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
Cap. Flow
-$778M
Cap. Flow %
-13.04%
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$51.8M
2
V icon
Visa
V
+$46.4M
3
CMCSA icon
Comcast
CMCSA
+$45.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$36.3M
5
NSC icon
Norfolk Southern
NSC
+$30.5M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$52.2M
2
SBUX icon
Starbucks
SBUX
+$51M
3
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$41.7M
4
LLY icon
Eli Lilly
LLY
+$40.3M
5
BKNG icon
Booking.com
BKNG
+$36.9M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Industrials 13.43%
3 Financials 12.16%
4 Consumer Discretionary 11.52%
5 Healthcare 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSIG
826
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$196K ﹤0.01%
+15,000
New +$176K
COHU icon
827
Cohu
COHU
$2.39B
$192K ﹤0.01%
+17,841
New +$184K
MOVE
828
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
$187K ﹤0.01%
16,200
-150,543
-90% -$2.03M
AMRC icon
829
Ameresco
AMRC
$1.15B
$178K ﹤0.01%
+23,539
New +$223K
PROV icon
830
Provident Financial
PROV
$108M
$177K ﹤0.01%
+11,507
New +$175K
NCIT
831
DELISTED
NCI, Inc.
NCIT
$172K ﹤0.01%
16,149
-18,000
-53% -$167K
OCRX
832
DELISTED
Ocera Therapeutics, Inc.
OCRX
$170K ﹤0.01%
+16,100
New +$230K
MTSN
833
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$166K ﹤0.01%
71,755
-71,200
-50% -$190K
ORN icon
834
Orion Group Holdings
ORN
$514M
$160K ﹤0.01%
+12,701
New +$145K
GSOL
835
DELISTED
Global Sources Ltd
GSOL
$158K ﹤0.01%
+17,645
New +$129K
FLWS icon
836
1-800-Flowers.com
FLWS
$245M
$157K ﹤0.01%
27,900
-83,193
-75% -$441K
ACLS icon
837
Axcelis
ACLS
$4.12B
$156K ﹤0.01%
18,096
-8,350
-32% -$76.8K
CRD.B icon
838
Crawford & Co Class B
CRD.B
$493M
$155K ﹤0.01%
14,233
-17,949
-56% -$164K
GYRE icon
839
Gyre Therapeutics
GYRE
$662M
$152K ﹤0.01%
41
– –
MATR
840
DELISTED
Mattersight Corp.
MATR
$147K ﹤0.01%
21,200
+1,600
+8% +$9.87K
ABR icon
841
Arbor Realty Trust
ABR
$960M
$137K ﹤0.01%
+19,800
New +$136K
DYAX
842
DELISTED
DYAX CORPORATION
DYAX
$136K ﹤0.01%
+15,100
New +$137K
MDXG icon
843
MiMedx Group
MDXG
$626M
$132K ﹤0.01%
+21,600
New +$159K
CLMS
844
DELISTED
Calamos Asset Management, Inc.
CLMS
$132K ﹤0.01%
+10,200
New +$122K
SUMR
845
DELISTED
Summer Infant, Inc.
SUMR
$129K ﹤0.01%
6,867
+3,791
+123% +$67.7K
RNWK
846
DELISTED
RealNetworks Inc
RNWK
$128K ﹤0.01%
16,864
– –
DCTH
847
DELISTED
Delcath Systems Inc
DCTH
$127K ﹤0.01%
1,766
-484
-22% -$39.2K
OIG
848
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$122K ﹤0.01%
+278
New +$100K
TSYS
849
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$119K ﹤0.01%
51,700
-14,200
-22% -$32.3K
SCLN
850
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$114K ﹤0.01%
24,970
-15,900
-39% -$76.8K
32 33
34
35 36

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q1 2014 Portfolio in Review

As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.

  • Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
  • Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
  • Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
  • Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
  • Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
  • Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.